140 related articles for article (PubMed ID: 26227563)
21. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Mieszczak J; Lowe ES; Plourde P; Eugster EA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
[TBL] [Abstract][Full Text] [Related]
22. Eight-year follow-up of a girl with McCune-Albright syndrome.
Aycan Z; Önder A; Çetinkaya S
J Clin Res Pediatr Endocrinol; 2011; 3(1):40-2. PubMed ID: 21448334
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and molecular study of Chilean patients with McCune-Albright syndrome].
Román R; Johnson MC; Codner E; Cattani A; García H; Mericq V; Boric A; Muñoz M; Schneider R; Cassorla F
Rev Med Chil; 2001 Dec; 129(12):1365-72. PubMed ID: 12080873
[TBL] [Abstract][Full Text] [Related]
24. Ovarian function in three female patients with McCune-Albright syndrome with persistent autonomous ovarian activity.
Maesaka H; Abe Y; Tachibana K; Adachi M; Asakura Y
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():903-11. PubMed ID: 12199349
[TBL] [Abstract][Full Text] [Related]
25. McCune-Albright syndrome associated with pituitary microadenoma: patient report.
Chen CJ; Liu JY; Cheng SN; Chang FW; Yuh YS
J Pediatr Endocrinol Metab; 2004 Mar; 17(3):365-9. PubMed ID: 15112914
[TBL] [Abstract][Full Text] [Related]
26. McCune-Albright syndrome--the German experience.
Albers N; Jörgens S; Deiss D; Hauffa BP
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():897-901. PubMed ID: 12199348
[TBL] [Abstract][Full Text] [Related]
27. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
28. McCune-Albright syndrome onset with vaginal bleeding.
Van Doan N; Minh Duc N; Kim Ngan V; Van Anh N
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34281944
[TBL] [Abstract][Full Text] [Related]
29. [Precocious puberty caused by McCune-Albright syndrome in a girl aged 6 years and 9 months].
Wikiera B; Wawro J; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):63-7. PubMed ID: 16704864
[TBL] [Abstract][Full Text] [Related]
30. Short stature and growth hormone deficiency: unexpected manifestations of McCune-Albright syndrome.
Pina Rivera Y; Rwegerera GM; Sesay S
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150346
[TBL] [Abstract][Full Text] [Related]
31. Virilizing sclerosing-stromal tumor of the ovary in a young woman with McCune Albright syndrome: clinical, pathological, and immunohistochemical studies.
Boussaïd K; Meduri G; Maiza JC; Gennero I; Escourrou G; Bros A; Leguevaque P; Bennet A; Caron P
J Clin Endocrinol Metab; 2013 Feb; 98(2):E314-20. PubMed ID: 23365131
[TBL] [Abstract][Full Text] [Related]
32. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
[TBL] [Abstract][Full Text] [Related]
33. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
34. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
Schmidt H; Kiess W
J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
[TBL] [Abstract][Full Text] [Related]
35. "Café-au-lait spots" caused by vitiligo in McCune-Albright syndrome.
Whyte MP; Podgornik MN; Zerega J; Reinus WR
J Bone Miner Res; 2000 Dec; 15(12):2521-3. PubMed ID: 11127218
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty].
Xu D; Lu W; Wang X; Wang J; Xie Y; Dong Z; Wang W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):291-296. PubMed ID: 32762164
[TBL] [Abstract][Full Text] [Related]
37. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
[TBL] [Abstract][Full Text] [Related]
38. McCune-Albright syndrome (MAS): early and extensive bone fibrous dysplasia involvement and "mistaken identity" oophorectomy.
Gucev Z; Tasic V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):837-42. PubMed ID: 21073128
[TBL] [Abstract][Full Text] [Related]
39. McCune-Albright syndrome: a case report in a male.
Patel KB
Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079331
[TBL] [Abstract][Full Text] [Related]
40. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
